EPISODE · Nov 18, 2023 · 26 MIN
Who gets the weight loss drugs when supply doesn’t meet demand?
from Reuters World News · host Reuters
A revolutionary new class of drugs is transforming weight loss. But around the world, demand is skyrocketing for diabetes drugs because they also help people shed pounds. Join our global health journalists as we explore access to drugs like Wegovy and Ozempic and the transformation of the way we understand weight loss. Learn more about your ad choices. Visit megaphone.fm/adchoices
Embed this episode
NOW PLAYING
Who gets the weight loss drugs when supply doesn’t meet demand?
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.